Skip to main content
. 2014 Jun 21;20(23):7452–7460. doi: 10.3748/wjg.v20.i23.7452

Table 2.

Basal characteristics and results of blood chemistry

Treatment group BDL+/Rapa- (n = 4) BDL+/Rapa+ (n = 7) BDL+/Rapa++ (n = 7) BDL-/Rapa- (n = 4) P value1
TBWt (g) 323.25 ± 85.84 351.28 ± 55.42 338.57 ± 21.16 276.25 ± 15.9 0.136
Liver Wt (g) 20.49 ± 2.68a 23.55 ± 4.90a 21.53 ± 3.10a 10.85 ± 0.38 < 0.0001
Liver Wt/TBWt 0.065 ± 0.011ac 0.069 ± 0.017a 0.064 ± 0.010ac 0.040 ± 0.003c 0.010
AST (U/L) 254.50 ± 143.79 244.43 ± 97.56 293.57 ± 89.67 86.75 ± 10.69 0.023
ALT (U/L) 47.00 ± 17.87 50.86 ± 21.97 52.00 ± 17.58 34.25 ± 2.63 0.429
TB (mg/dL) 9.15 ± 2.16a 8.74 ± 0.92a 11.17 ± 2.11a 0.50 ± 0.14 < 0.0001
TP (g/dL) 5.48 ± 1.28 5.37 ± 0.33 5.74 ± 0.61 5.48 ± 0.38 0.773
Alb (g/dL) 2.65 ± 0.85a 2.81 ± 0.41a 3.43 ± 0.43a 3.83 ± 0.33 0.008
1

Statistical significances were tested by one-way analysis of variances among groups and statistically significant results are indicated by P values.

a

P < 0.05 vs BDL-/Rapa-;

c

P < 0.05 vs BDL+/Rapa+ based on Scheffe multiple comparison test. Basal characteristics and results of blood chemistry in bile duct ligation (BDL+/Rapa-), bile duct ligation with rapamycin (BDL+/Rapa+, BDL+/Rapa++) and sham-operated (BDL-/Rapa-) groups. Each values indicate mean ± SD. TBWt: Total body weight; Wt: Weight; TP: Total protein; Alb: Abumin; AST: Aspartate transaminase; ALT: Alanine transaminase; TB: Total bilirubin; Rapa: Rapamycin; Rapa+: Rat administered rapamycin for 28 d from the 14th day post-BDL; Rapa++: Rat administered rapamycin for 28 d beginning the first day post-BDL.